Designing a Roadmap for Health Technology Assessment Implementation in Algeria.

Autor:	Hedibel M; Pharmaceutics and Industrial Pharmacy Research Laboratory, Faculty of Pharmacy, University of Algiers, Algiers, DZA., Ghanassi FZ; Pharmaceutics and Industrial Pharmacy Research Laboratory, Faculty of Pharmacy, University of Algiers, Algiers, DZA., El-Fass KA; Health Economics, Syreon Middle East, Alexandria, EGY., Fasseeh AN; Modelling, Syreon Middle East, Alexandria, EGY.; Faculty of Pharmacy, Alexandria University, Alexandria, EGY., Abaza S; Health Economics, Syreon Middle East, Cairo, EGY., Kaló Z; Health Economics, Syreon Research Institute, Budapest, HUN.; Center for Health Technology Assessment, Semmelweis University, Budapest, HUN.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Jul 28; Vol. 16 (7), pp. e65558. Date of Electronic Publication: 2024 Jul 28 (Print Publication: 2024).
DOI:	10.7759/cureus.65558
Abstrakt:	Background The scarcity of resources restricts healthcare financing decisions, affecting the population's health. Health technology assessment (HTA) balances restricted budgets with the best possible health outcomes. We aim to characterize the current status of HTA in Algeria and describe the future directions for HTA implementation according to the priorities set by local stakeholders. Methods Stakeholders from the public and private sectors responded to a policy survey about the current and preferred future status of HTA implementation in Algeria. The survey was administered during an online workshop and used a widely accepted international scorecard covering eight domains: capacity building, HTA financing, process and organizational structure, scope of HTA implementation, decision criteria, standardization of methodology, use of local data, and international collaboration. After that, one-on-one interviews with another local expert were conducted to validate and modify the draft recommendations. The interviewees were representatives from government agencies, hospitals, and pharmaceutical companies. Results Thirty-one experts filled out the HTA scorecard survey; most of them were from the public sector (74%). They highlighted that project-based HTA workshops or short courses were the most common form of HTA education in Algeria and recommended the establishment of postgraduate HTA training programs in the future to build sustainable capacities. They reported a lack of funding for HTA research and critical appraisal and recommended an increased public budget for HTA and the introduction of submission fees by manufacturers. There was consensus about the need for local HTA evidence generation in the future. Most of the experts advocated an explicit soft decision threshold. The interviewees further recommended using multi-criteria decision analysis in the short term. The application of quality indicators was believed to improve the reliability of the HTA process. Conclusion The results of our policy research delineate the gap between the current and preferred future status of HTA in Algeria based on insights from multiple stakeholders. The need to improve the educational HTA programs in Algeria, use local data in policy decisions, and increase funding for HTA were the most advocated recommendations. Competing Interests: Human subjects: Consent was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: Abbvie funded this study and contracted Syreon to conduct the study. However, Abbvie had no role in the design, analysis, or interpretation of the results. Financial relationships: Zoltán Kaló, Sherif Abaza, Ahmad Nader Fasseeh, Kareem A. El-Fass declare(s) employment and stock/stock options from Syreon. Syreon Middle East was a contractual partner of Abbvie. ANF, SA and ZK are shareholders in Syreon Middle East. KF is an employee at Syreon Middle East. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work. (Copyright © 2024, Hedibel et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu